FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/02/031412 [Registered on: 19/02/2021] Trial Registered Prospectively
Last Modified On: 17/02/2021
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective observational 
Study Design  Other 
Public Title of Study   Compare the standardised mortality rate with the actual mortality rate of the severely infected patients admitted in ICU using two scoring system used in icu (APACHE-IV and SAPS-II)  
Scientific Title of Study   A Comparative study of actual mortality rate with standardised mortality rate calculated by APACHE-IV and SAPS-II in severe sepsis and septic shock patients: A prospective observational study. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Swarnika Singh 
Designation  Junior Resident 
Affiliation  Indira Gandhi Institute of Medical Sciences,patna 
Address  Department of Anaesthesia, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, Bihar.

Patna
BIHAR
800014
India 
Phone  8420445989  
Fax    
Email  swarnika001@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  vinod kumar verma 
Designation  professor 
Affiliation  Indira Gandhi Institute of Medical Sciences,patna 
Address  Department of Anaesthesia, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, Bihar.

Patna
BIHAR
800014
India 
Phone  8292000111  
Fax    
Email  drvvinodv@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Swarnika Singh 
Designation  Junior Resident 
Affiliation  Indira Gandhi Institute of Medical Sciences,patna 
Address  Department of Anaesthesia, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, Bihar.

Patna
BIHAR
800014
India 
Phone  8420445989  
Fax    
Email  swarnika001@gmail.com  
 
Source of Monetary or Material Support  
Indira Gandhi Institute of Medical Sciences,Patna 
 
Primary Sponsor  
Name  Swarnika Singh 
Address  Department of Anaesthesia, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, Bihar.  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Swarnika Singh  Indira Gandhi Institute of Medical Sciences, Patna  Department of Anaesthesiology, Ward Block First Floor, Patna, Bihar
Patna
BIHAR 
8420445989

swarnika001@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE,IGIMS,PATNA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: A419||Sepsis, unspecified organism,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients admitted in Medical ICU meeting the diagnostic criteria for severe sepsis and septic shock during the first 24 hr of admission will be included in our study. 
 
ExclusionCriteria 
Details  1. Patient/patient’s party refuse to participate,
2. Age <18 years and >70 years.
3. Patients whose duration of stay in ICU was less than 4 h.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To compare the accuracy of the APACHE IV and SAPS II scoring system in predicting mortality rate among patients admitted with severe sepsis and septic shock in our ICU  length of stay in ICU 
 
Secondary Outcome  
Outcome  TimePoints 
1.To calculate predicted mortality rate using APACHE-IV Scoring System in patients of severe sepsis and septic shock.
2. To calculate predicted mortality rate using SAPS-II Scoring System in patients of severe sepsis and septic shock.
3. To compare the Actual Length of stay in ICU with the APACHE IV predicted Length of Stay in patients of severe sepsis and septic shock.
 
0hr, 6hrs, 12hr and 24hrs from the time of admission in ICU  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   24/02/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response (Others) - 

  6. For how long will this data be available start date provided 15-02-2021 and end date provided 14-02-2022?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Sepsis is defined as life threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis remains an important cause of ICU admission, and despite advances in antibiotics and refined supportive care, mortality due to sepsis remains leading cause of death in non-coronary ICU.
There are several scoring system which have been developed to calculate and predict the mortality rate in critically ill patients.
APACHE is the first scoring system used to determine the prognosis of the patient. SAPS scoring system was developed later. SAPS-II is the most widely used scoring system in European  ICU.
we are aiming to calculate the predicted mortality rate, with the help of two scoring systems, APACHE-IV and SAPS-II, and compare it with the actual mortality rate encountered in our ICU.
 
Close